ABCELLERA BIOLOGICS INC (ABCL) Stock Earnings & Estimates
USA - NASDAQ:ABCL - CA00288U1066 - Common Stock
3.62 USD
-0.35 (-8.82%)
3.5 USD
-0.12 (-3.31%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 485.4M 29.37% | 38.025M -92.17% | 28.833M -24.17% | 33.732M 16.99% | 54.954M 62.91% | 46.713M -15.00% | 125.17M 167.96% | 173.84M 38.88% | 209.86M 20.72% | 112.76M -46.27% | 128.52M 13.98% | |
| EBITDA YoY % growth | 244.4M 11.65% | -212.812M -187.08% | -223.917M -5.22% | -241.672M -7.93% | -308.215M -27.53% | -282.234M 8.43% | -224.91M 20.31% | -223.278M 0.73% | -224.196M -0.41% | -226.542M -1.05% | N/A | |
| EBIT YoY % growth | 216.5M 5.92% | -237.207M -209.56% | -314.766M -32.70% | -251.612M 20.06% | -263.017M -4.53% | -279.729M -6.35% | -208.047M 25.63% | -175.315M 15.73% | -150.809M 13.98% | -242.76M -60.97% | -227.46M 6.30% | |
| Operating Margin | 44.60% | -623.82% | -1,091.69% | -745.92% | -478.61% | -598.82% | -166.21% | -100.85% | -71.86% | -215.29% | -176.98% | |
| EPS YoY % growth | 0.50 6.38% | -0.52 -204.00% | -0.55 -5.77% | -0.62 -13.13% | -0.59 5.39% | -0.73 -24.32% | -0.29 60.28% | -0.12 59.65% | -0.01 91.30% | -0.59 -5,700.00% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 -49.52% | -0.15 0.72% | -0.16 -30.33% | -0.12 37.37% | -0.12 27.65% |
| Revenue Q2Q % growth | 6.368M 26.10% | 8.613M 103.38% | 16.052M -6.04% | 10.098M 12.76% | 10.455M 64.18% |
| EBITDA Q2Q % growth | -65.282M -460.79% | -62.031M -8.20% | -120.75M -211.35% | -71.023M -17.92% | -73.928M -13.24% |
| EBIT Q2Q % growth | -67.36M 7.42% | -63.259M -0.96% | -107.412M -116.62% | -63.039M 17.36% | -63.353M 5.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.19 -11.76% | -0.17 | -0.02 | -10.38% |
| Q2 2025 Q2Q % growth | -0.12 7.69% | -0.17 | 0.05 | 29.13% |
| Q1 2025 Q2Q % growth | -0.15 -7.14% | -0.14 | -0.01 | -3.56% |
| Q4 2024 Q2Q % growth | -0.11 35.29% | -0.16 | 0.05 | 29.86% |
| Q3 2024 Q2Q % growth | -0.17 -70.00% | -0.15 | -0.02 | -9.89% |
| Q2 2024 Q2Q % growth | -0.13 -18.18% | -0.15 | 0.02 | 11.08% |
| Q1 2024 Q2Q % growth | -0.14 | -0.17 | 0.03 | 17.44% |
| Q4 2023 Q2Q % growth | -0.17 -70.00% | -0.13 | -0.04 | -26.05% |
| Q3 2023 Q2Q % growth | -0.10 -225.00% | -0.14 | 0.04 | 27.08% |
| Q2 2023 Q2Q % growth | -0.11 -450.00% | -0.13 | 0.02 | 17.04% |
| Q1 2023 Q2Q % growth | -0.14 -125.93% | -0.14 | 0.00 | -1.14% |
| Q4 2022 Q2Q % growth | -0.10 -152.63% | -0.01 | -0.09 | -1,767.41% |
| Q3 2022 Q2Q % growth | 0.08 200.00% | 0.05 | 0.03 | 72.64% |
| Q2 2022 Q2Q % growth | -0.02 -100.00% | -0.02 | 0.00 | -25.93% |
| Q1 2022 Q2Q % growth | 0.54 45.95% | 0.39 | 0.15 | 37.82% |
| Q4 2021 Q2Q % growth | 0.19 -56.82% | 0.19 | 0.00 | -1.35% |
| Q3 2021 Q2Q % growth | -0.08 | -0.05 | -0.03 | -49.39% |
| Q2 2021 Q2Q % growth | -0.01 | 0.08 | -0.09 | -112.61% |
| Q1 2021 Q2Q % growth | 0.37 | 0.39 | -0.02 | -4.10% |
| Q4 2020 Q2Q % growth | 0.44 | 0.62 | -0.18 | -29.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 8.955M 37.62% | 6.027M | 2.928M | 48.58% |
| Q2 2025 Q2Q % growth | 17.084M 133.29% | 6.242M | 10.842M | 173.69% |
| Q1 2025 Q2Q % growth | 4.235M -57.45% | 7.678M | -3.443M | -44.84% |
| Q4 2024 Q2Q % growth | 5.05M -44.98% | 7.731M | -2.681M | -34.68% |
| Q3 2024 Q2Q % growth | 6.507M -1.39% | 8.109M | -1.602M | -19.76% |
| Q2 2024 Q2Q % growth | 7.323M -27.18% | 10.356M | -3.033M | -29.29% |
| Q1 2024 Q2Q % growth | 9.954M -18.36% | 11.052M | -1.098M | -9.93% |
| Q4 2023 Q2Q % growth | 9.179M -57.31% | 9.062M | 117K | 1.29% |
| Q3 2023 Q2Q % growth | 6.599M -93.49% | 12.08M | -5.481M | -45.37% |
| Q2 2023 Q2Q % growth | 10.056M -78.09% | 12.616M | -2.56M | -20.29% |
| Q1 2023 Q2Q % growth | 12.192M -96.15% | 12.351M | -159K | -1.29% |
| Q4 2022 Q2Q % growth | 21.5M -84.57% | 51.817M | -30.317M | -58.51% |
| Q3 2022 Q2Q % growth | 101.4M 1,743.64% | 76.453M | 24.947M | 32.63% |
| Q2 2022 Q2Q % growth | 45.9M 66.30% | 54.661M | -8.761M | -16.03% |
| Q1 2022 Q2Q % growth | 316.6M 56.19% | 224.14M | 92.46M | 41.25% |
| Q4 2021 Q2Q % growth | 139.3M -33.00% | 124.49M | 14.81M | 11.90% |
| Q3 2021 Q2Q % growth | 5.5M -78.22% | 12.848M | -7.348M | -57.19% |
| Q2 2021 Q2Q % growth | 27.6M 146.43% | 72.938M | -45.338M | -62.16% |
| Q1 2021 Q2Q % growth | 202.7M | 200.41M | 2.29M | 1.14% |
| Q4 2020 Q2Q % growth | 207.9M 6,396.88% | 201M | 6.9M | 3.43% |
| Q3 2020 Q2Q % growth | 25.247M 200.23% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.66% | 0% | 8.96% |
| Revenue | 0% | -2.51% | 0% | 56.38% |